| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | SELL | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 3.12▲ | 3.07▲ | 3.05▲ | 3.24▼ | 3.19▼ |
| MA10 | 3.13▲ | 3.00▲ | 3.01▲ | 3.47▼ | 2.65▲ |
| MA20 | 3.10▲ | 2.98▲ | 3.02▲ | 3.21▼ | 2.56▲ |
| MA50 | 3.01▲ | 3.13▲ | 3.38▼ | 2.60▲ | 2.22▲ |
| MA100 | 2.98▲ | 3.42▼ | 3.39▼ | 2.54▲ | 2.52▲ |
| MA200 | 3.10▲ | 3.34▼ | 2.91▲ | 2.22▲ | 2.46▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.001▼ | 0.037▲ | 0.041▲ | -0.075▼ | 0.122▲ |
| RSI | 67.798▲ | 61.904▲ | 51.958▲ | 52.382▲ | 60.462▲ |
| STOCH | 38.940 | 62.954 | 60.115 | 35.617 | 69.164 |
| WILL %R | -24.242▲ | -13.333▲ | -12.121▲ | -75.081▼ | -42.654 |
| CCI | 117.829▲ | 175.249▲ | 182.731▲ | -88.071 | 122.526▲ |
|
Thursday, November 06, 2025 10:39 AM
Immix Biopharma, Inc. is building strength in its pipeline with impressive early signals in AL amyloidosis. Learn more about IMMX stock here.
|
|
Monday, November 03, 2025 08:48 AM
Oral presentation Sunday, December 7, at ASH 2025 - LOS ANGELES, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. ("ImmixBio", "Company", "We" or "Us" or "IMMX"), the global leader in relapsed/ ...
|
|
Thursday, October 30, 2025 08:35 PM
Immix Biopharma, Inc. (“ImmixBio”, “Company”, “We” or “Us” or ”IMMX”), the global leader in relapsed/refractory AL Amyloidosis, today announced that it will present and host institutional investor ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 07/11/25 | 3.01 | 3.22 | 2.8901 | 3.15 | 457,450 |
| 06/11/25 | 3.06 | 3.12 | 2.8513 | 3.03 | 601,453 |
| 05/11/25 | 3.31 | 3.46 | 3.00 | 3.05 | 627,754 |
| 04/11/25 | 3.58 | 3.58 | 3.24 | 3.33 | 684,264 |
| 03/11/25 | 3.79 | 3.90 | 3.41 | 3.64 | 900,738 |
| 31/10/25 | 3.76 | 4.05 | 3.70 | 3.80 | 1,616,007 |
| 30/10/25 | 3.74 | 3.8499 | 3.60 | 3.67 | 288,635 |
| 29/10/25 | 3.90 | 3.924 | 3.60 | 3.72 | 883,203 |
| 28/10/25 | 3.42 | 4.00 | 3.40 | 3.90 | 1,245,876 |
| 27/10/25 | 3.67 | 3.71 | 3.26 | 3.39 | 822,916 |
|
|
||||
|
|
||||
|
|